Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Donohue, H. Pincus (2012)
Reducing the Societal Burden of DepressionPharmacoEconomics, 25
R. Belmaker, G. Agam (2008)
Major depressive disorder.The New England journal of medicine, 358 1
A. Coppen, J. Bailey (2000)
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.Journal of affective disorders, 60 2
J. Sarris, D. Mischoulon, I. Schweitzer (2012)
Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.The Journal of clinical psychiatry, 73 1
M. Fava, A. Rush, M. Trivedi, A. Nierenberg, M. Thase, H. Sackeim, F. Quitkin, S. Wisniewski, P. Lavori, J. Rosenbaum, D. Kupfer (2003)
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.The Psychiatric clinics of North America, 26 2
J. Ayuso-Mateos, J. Vázquez-Barquero, C. Dowrick, V. Lehtinen, O. Dalgard, P. Casey, C. Wilkinson, L. Lasa, H. Page, G. Dunn, G. Wilkinson (2001)
Depressive disorders in Europe: prevalence figures from the ODIN studyBritish Journal of Psychiatry, 179
G. Grosso, F. Galvano, S. Marventano, M. Malaguarnera, C. Bucolo, F. Drago, F. Caraci (2014)
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological MechanismsOxidative Medicine and Cellular Longevity, 2014
M. Fava, D. Mischoulon (2010)
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.The Journal of clinical psychiatry, 70 Suppl 5
S. Meyers (2000)
Use of neurotransmitter precursors for treatment of depression.Alternative medicine review : a journal of clinical therapeutic, 5 1
E. Kalra (2008)
Nutraceutical-definition and introductionAAPS PharmSci, 5
J. Martins (2009)
EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled TrialsJournal of the American College of Nutrition, 28
J. Bourre (2004)
Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing.The journal of nutrition, health & aging, 8 3
N. Kresge, H. Tabor, R. Simoni, R. Hill (2005)
An escape from Italy, the discovery of S-adenosylmethionine, and the biosynthesis of creatine by Giulio L. Cantoni. 1953.The Journal of biological chemistry, 280 38
G. Cantoni (1952)
THE NATURE OF THE ACTIVE METHYL DONOR FORMED ENZYMATICALLY FROM L-METHIONINE AND ADENOSINETRIPHOSPHATE1,2Journal of the American Chemical Society, 74
William Byerley, Lewis Judd, Fred Reimherr, Bernard Grosser (1987)
5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.Journal of clinical psychopharmacology, 7 3
R. Shippy, D. Mendez, K. Jones, Irene Cergnul, Stephen Karpiak (2004)
S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDSBMC Psychiatry, 4
P. Herman, B. Poindexter, C. Witt, D. Eisenberg (2012)
Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluationsBMJ Open, 2
C. Curran, M. Knapp, D. McDaid, K. Tomasson (2007)
Mental health and employment: An overview of patterns and policies across Western EuropeJournal of Mental Health, 16
Maurizio Fava, J. Borus, J. Alpert, A. Nierenberg, J. Rosenbaum, Teodoro Bottiglieri (1997)
Folate, vitamin B12, and homocysteine in major depressive disorder.The American journal of psychiatry, 154 3
Jessica Gören, A. Stoll, K. Damico, Ingrid Sarmiento, Bruce Cohen (2004)
Bioavailability and Lack of Toxicity of S‐Adenosyl‐l‐Methionine (SAMe) in HumansPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 24
P. Sobocki, B. Jönsson, J. Angst, C. Rehnberg (2006)
Cost of depression in Europe.The journal of mental health policy and economics, 9 2
T. Bottiglieri, T. Chary, M. Laundy, M. Carney, P. Godfrey, B. Toone, E. Reynolds (1988)
Transmethylation in depression.The Alabama journal of medical sciences, 25 3
G. Papakostas (2009)
Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.The Journal of clinical psychiatry, 70 Suppl 5
R. Baldessarini (1987)
Neuropharmacology of S-adenosyl-L-methionine.The American journal of medicine, 83 5A
Michael Maes, Raz Yirmyia, J. Noraberg, S. Brené, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, M. Maj (2009)
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depressionMetabolic Brain Disease, 24
A. Coppen, C. Bolander-Gouaille (2005)
Treatment of depression: time to consider folic acid and vitamin B12Journal of Psychopharmacology, 19
K. Shaw, J. Turner, C. Mar (2002)
Are Tryptophan and 5-Hydroxytryptophan Effective Treatments for Depression? A Meta-Analysis∗Australian and New Zealand Journal of Psychiatry, 36
W. Severus, A. Littman, A. Stoll (2001)
Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.Harvard review of psychiatry, 9 6
PurposeThe purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system.Design/methodology/approachThe literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals.FindingsThe results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression.Practical implicationsRandomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression.Social implicationsNutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual.Originality/valueNutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects.
World Journal of Science Technology and Sustainable Development – Emerald Publishing
Published: Jan 7, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.